DOXGX | ZDIVX | DOXGX / ZDIVX | |
Total Expense Ratio | 0.41 | 1.30 | 32% |
Annual Report Gross Expense Ratio | 0.46 | 1.31 | 35% |
Fund Existence | 3 years | 11 years | - |
Gain YTD | 7.699 | 8.005 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 129M | 88,372% |
Annual Yield % from dividends | 1.47 | 1.89 | 78% |
Returns for 1 year | 8.43 | 11.67 | 72% |
Returns for 3 years | 32.25 | 23.25 | 139% |
Returns for 5 years | N/A | 58.65 | - |
Returns for 10 years | N/A | 94.90 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MVISX | 46.06 | 0.47 | +1.03% |
Patient Opportunity IS | |||
MIISX | 7.65 | 0.04 | +0.53% |
BNY Mellon Income Stock Inv | |||
MSEPX | 23.09 | 0.12 | +0.52% |
Morgan Stanley Inst Emerging Mkts C | |||
MIDBX | 31.64 | 0.08 | +0.25% |
MFS International New Discovery B | |||
FSQAX | 10.82 | -0.01 | -0.09% |
Fidelity Advisor Sustainable Intl Eq A |